NCT03329911 - A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer | Biotech Hunter

Enrollment

651

Participants

Timeline

Start Date

October 20, 2017

Primary Completion Date

November 5, 2019

Study Completion Date

May 27, 2021

Conditions

Non-squamous Non-small Cell Lung Cancer

Interventions

DRUG

EU Avastin®

100 mg/4 mL

DRUG

BAT1706

100 mg/4 mL

DRUG

Paclitaxel

200 mg/m²

DRUG

carboplatin

target area under the curve \[AUC\] 6 mg/mL•minute

Trial Locations (5)

Baskent University Ankara Hospital, Ankara

National Hospital Oncology, Bloemfontein

CI Kryvyi Rih Oncological Dispensary of DRC, Kryvyi Rih

Clinical Medical Research S.C., Orizaba

The First Affiliated Hospital of Xiamen University, Xiamen